Xtant Medical Holdings (XTNT) EBITDA Margin Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 220.00 |
| Jun 30, 2025 | 1,675.00 |
| Mar 31, 2025 | 1,245.00 |
| Dec 31, 2024 | 2,340.00 |
| Sep 30, 2024 | -1,412.00 |
| Jun 30, 2024 | -1,074.00 |
| Mar 31, 2024 | -1,324.00 |
| Dec 31, 2023 | 3,252.00 |
| Sep 30, 2023 | -985.00 |
| Jun 30, 2023 | 42.00 |
| Mar 31, 2023 | -345.00 |
| Dec 31, 2022 | 10,990.00 |
| Sep 30, 2022 | 43.00 |
| Jun 30, 2022 | 1,658.00 |
| Mar 31, 2022 | -664.00 |
| Dec 31, 2021 | -1,005.00 |
| Sep 30, 2021 | -559.00 |
| Jun 30, 2021 | 317.00 |
| Mar 31, 2021 | 809.00 |
| Dec 31, 2020 | 1,480.00 |
| Sep 30, 2020 | 3,176.00 |
| Jun 30, 2020 | 856.00 |
| Mar 31, 2020 | 727.00 |
| Dec 31, 2019 | 2,264.00 |
| Sep 30, 2019 | 1,416.00 |
| Jun 30, 2019 | 1,438.00 |
| Mar 31, 2019 | 1,248.00 |
| Dec 31, 2018 | -659.00 |
| Sep 30, 2018 | 2,374.00 |
| Jun 30, 2018 | 1,334.00 |
| Mar 31, 2018 | 687.00 |
| Dec 31, 2017 | -4,664.00 |
| Sep 30, 2017 | -1,779.00 |
| Jun 30, 2017 | -2,289.00 |
| Mar 31, 2017 | 638.00 |
| Dec 31, 2016 | 2,347.00 |
| Sep 30, 2016 | 1,325.00 |
| Jun 30, 2016 | -478.00 |
| Mar 31, 2016 | 2,487.00 |
| Dec 31, 2015 | 6,122.00 |
| Sep 30, 2015 | 2,522.00 |
| Jun 30, 2015 | 2,291.00 |